Engineered extracellular vesicles antagonize SARS-CoV-2 infection by inhibiting mTOR signaling

Effective treatment approaches for patients with COVID-19 remain limited and are neither curative nor widely applicable. Activated specialized tissue effector extracellular vesicles (ASTEX) derived from genetically-enhanced skin fibroblasts, exert disease-modifying bioactivity in vivo in models of h...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, A.G., Ciullo, A., Li, C., Garcia, G., Peck, K., Miyamoto, K., Arumugaswami, V., Marbán, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
VSI: TERMIS 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841010/
https://www.ncbi.nlm.nih.gov/pubmed/35187508
http://dx.doi.org/10.1016/j.bbiosy.2022.100042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841010/
https://www.ncbi.nlm.nih.gov/pubmed/35187508
http://dx.doi.org/10.1016/j.bbiosy.2022.100042

Ejemplares similares